With opioid utilization decreasing, what concerns do other pain therapies pose?
With opioid utilization decreasing, what concerns do other pain therapies pose?
A new white paper explores clinical, legislative, workplace safety, and PBM considerations surrounding marijuana.
Congress may soon clear federal restrictions to processing marijuana transactions, while the FDA asks for feedback on handling marijuana products.
Dr. Robert Goldberg and Sandy Shtab talk with Risk & Insurance about changing attitudes and policies around medical marijuana, its potential role in reducing reliance on opioids, and what this can mean for payers, employers, patients and PBMs.
As 2018’s legislative trends continue to spill into 2019, what big initiatives might impact workers’ comp this year?
Marijuana use among adults aged 50-64 tripled from 2002-2014.
The marijuana-derived seizure drug now sits at schedule V, facing far fewer prescribing and dispensing restrictions.
Assembly No. 4505 may solidify precedence recently made by a judge from the Division of Workers’ Compensation.
More states cover PTSD without physical injuries for first responders, and 24 states allow PTSD patients to use medical marijuana.
Senate Bill 336 passed with a 44-6 vote and is now headed to the House.
